Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2293 (LINC02293) is a human long non-coding RNA (lncRNA) gene located on chromosome 14 (14q11.2). LINC02293 belongs to the class of long intergenic non-coding RNAs, RNA molecules greater than 200 nucleotides in length that do not encode proteins. While lncRNAs as a class are involved in diverse regulatory roles—including chromatin remodeling, transcriptional, and post-transcriptional gene regulation—there is no experimentally validated biological function, interaction, or disease association specifically reported for LINC02293 to date. LncRNAs have been shown to play roles in cancer and can serve as diagnostic or prognostic markers, but those findings are not specific to this gene and no drug interactions, biomarker utility, or safety data exist for LINC02293 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2293 (LINC02293).